Fidia Pharma USA

Fidia Pharma USA

Fidia provides a complete HA portfolio for osteoarthritis knee pain. Our hyaluronan-based viscosupplements include HYALGAN®, the first HA approved in the US; 3-injection TRILURON®; HYMOVIS® the only 2-injection non-crosslinked hydrogel; and now HYMOVIS® ONE the only single-injection, non-avian, non-crosslinked HA. Fidia also has RichPlat Ortho™ Platelet Rich Plasma System that delivers high-quality PRP with a closed-system kit. Visit fidiapharma.us to learn more.

Orthotic and Prosthetic Devices/Services, Pain Management, Pharmaceutical Manufacturers, Physical Therapy Products & Testing, Rehabilitation Programs

Yes